ELGAR HOUSE — All Prescriptions & Medications — Page 4
Practice Code: M81002 | REDDITCH, B97 4AB
Showing results 151-200 of 600
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Calcipotriol | 289 | 28.1K | £15.1K | +69.8% ▲ |
| Dexamethasone | 287 | 1,650 | £1.0K | +66.9% ▲ |
| Clobetasone butyrate | 284 | 16.2K | £1.4K | +39.1% ▲ |
| Baclofen | 279 | 72.3K | £1.1K | +39.3% ▲ |
| Fluticasone/umeclidinium/vilanterol | 277 | 476 | £20.1K | +18.2% ▲ |
| Medroxyprogesterone acetate | 275 | 280 | £1.6K | +127.8% ▲ |
| Lisinopril | 274 | 15.0K | £332 | -75.0% ▼ |
| Betahistine hydrochloride | 274 | 27.8K | £863 | +14.8% ▲ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 273 | 9,352 | £941 | +78.7% ▲ |
| Glyceryl trinitrate | 267 | 1,200 | £749 | +12.9% ▲ |
| 265 | 26.7K | £2.2K | +22.5% ▲ | |
| Tiotropium bromide | 261 | 5,459 | £11.1K | -14.2% ▼ |
| Sacubitril/valsartan | 257 | 15.1K | £24.8K | +7.3% ▲ |
| Cyclizine hydrochloride | 257 | 14.0K | £746 | +59.3% ▲ |
| Powder 1.6 kcal/ml milkshake (0913011) | 257 | 5,433 | £2.9K | +244.7% ▲ |
| Sitagliptin | 254 | 9,989 | £700 | -34.9% ▼ |
| Diphtheria | 252 | 252 | £1.9K | +277.6% ▲ |
| Brinzolamide | 248 | 2,640 | £1.9K | +90.9% ▲ |
| Fusidic acid | 240 | 6,225 | £748 | +88.0% ▲ |
| Aciclovir | 238 | 11.4K | £527 | +60.0% ▲ |
| Bimatoprost | 234 | 1,545 | £2.1K | +57.4% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 231 | 31.2K | £1.9K | +2.2% ▲ |
| Carvedilol | 230 | 13.8K | £436 | +102.7% ▲ |
| Clotrimazole | 230 | 2,328 | £2.0K | +108.5% ▲ |
| 230 | 41.2K | £1.5K | -16.8% ▼ | |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 229 | 399 | £17.6K | +36.9% ▲ |
| Sulfasalazine | 228 | 34.1K | £11.7K | +75.2% ▲ |
| 228 | 3,160 | £628 | +9.1% ▲ | |
| Co-beneldopa (Benserazide/levodopa) | 225 | 30.3K | £1.8K | +48.8% ▲ |
| Aripiprazole | 222 | 6,889 | £816 | -12.8% ▼ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 221 | 329 | £4.6K | +94.8% ▲ |
| Biphasic insulin aspart | 220 | 1,935 | £11.5K | +116.7% ▲ |
| Estradiol | 217 | 5,664 | £2.8K | -19.6% ▼ |
| Bumetanide | 213 | 11.3K | £1.3K | -21.8% ▼ |
| Anastrozole | 212 | 9,854 | £372 | +132.8% ▲ |
| Insulin degludec | 211 | 1,523 | £16.3K | +92.0% ▲ |
| Ferrous fumarate | 209 | 17.8K | £583 | -71.2% ▼ |
| Umeclidinium bromide/vilanterol | 206 | 379 | £11.7K | +5.6% ▲ |
| Miconazole nitrate | 205 | 9,300 | £1.5K | +189.8% ▲ |
| Fluticasone furoate | 204 | 236 | £1.6K | +5.3% ▲ |
| Clobetasol propionate | 202 | 14.6K | £1.1K | +48.1% ▲ |
| Hyoscine butylbromide | 198 | 18.6K | £1.3K | -15.0% ▼ |
| Tirzepatide | 194 | 261 | £25.2K | -0.1% vs avg |
| Eplerenone | 190 | 5,876 | £727 | -28.4% ▼ |
| Nifedipine | 189 | 16.0K | £3.6K | +0.8% vs avg |
| Biphasic insulin lispro | 182 | 1,740 | £10.7K | +323.9% ▲ |
| Pizotifen malate | 181 | 9,828 | £419 | +119.6% ▲ |
| Hypromellose | 179 | 3,170 | £612 | +35.1% ▲ |
| Fluticasone propionate (Nasal) | 179 | 1,529 | £2.6K | +22.9% ▲ |
| Mesalazine (Systemic) | 177 | 26.5K | £12.2K | -26.1% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.